Clinical trialNCT02694770WithdrawnPhase 2Interventional

A Study Evaluating the Efficacy and Safety of Neihulizumab vs "Conventional Treatment" to Treat Sr-aGvHD

SponsorAbGenomics B.V Taiwan BranchEnrollment0Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is to assess the efficacy of Neihulizumab versus "conventional therapy" and to evaluate safety, pharmacokinetics and immunogenicity in treating steroid-refractory acute Graft-vs-Host Disease

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Amin Alousi (Co-Lead), MD
M.D. Anderson Cancer Center
Principal Investigator
clinicaltrials.gov ↗
Marco Mielcarek (Co-Lead), MD
Fred Hutchinson Cancer Center
Principal Investigator
clinicaltrials.gov ↗
Paul Martin (Lead), MD
Fred Hutchinson Cancer Center
Principal Investigator
clinicaltrials.gov ↗
Shih-Yao Lin, MD, PhD
AbGenomics B.V.
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Md Anderson Cancer Center
Houston, Texas, United States
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Conventional TreatmentNeihulizumab Treatment

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jul 2016
Primary completion: 30 Sept 2017
Completion: 28 Feb 2018
Last update posted: 25 Apr 2016
Registered enrollment: 0
Registry id: NCT02694770

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.